Angiogenin抗体と関連製品
Santa Cruz Biotechnology社は、様々な生物学的プロセスにおけるアンジオジェニンの役割の理解に焦点を当てた研究のために、多種多様なアンジオジェニンモノクローナル抗体を提供しています。モノクローナル抗体は、ウェスタンブロッティング（WB）、免疫沈降（IP）、免疫蛍光（IF）、パラフィン包埋切片を用いた免疫組織化学（IHCP）、フローサイトメトリー（FCM）、酵素結合免疫吸着測定法（ELISA）に適しています。アンジオジェニンは、既存の血管から新しい血管が形成される過程である血管新生の制御に関与する重要なタンパク質である。アンジオジェニンは、特に低酸素状態に応答して、細胞の増殖と生存を促進する重要な役割を果たしている。アンジオジェニンの機能を理解することは、癌の進行、創傷治癒、様々な心血管系疾患におけるアンジオジェニンの意味を探る上で不可欠である。研究者はアンジオジェニンの細胞内シグナル伝達経路への関与や他の分子との相互作用を調べることができる。アンジオジェニンの研究はRNA代謝や細胞ストレス応答との重要な関連を明らかにしてきた。現在の研究は、発生と疾患におけるアンジオジェニンの新しい機能を明らかにし続けている。Santa Cruz Biotechnologyのモノクローナル抗体により、世界中の研究者は、ヒトの健康と疾患におけるアンジオジェニンの役割に関する科学的理解を深めることができます。
Angiogenin 抗体
| Empty Table Header | 製品名 | CATALOG # | アイソタイプ | エピトープ | アプリケーション | Species | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|---|
ANG I 抗体 (C-1) | sc-74528 | mouse IgG2a κ | 25-147 (h) | WB, IP, IF, ELISA | m, r, h | 23 |
Angiogenin CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ANG I CRISPR/Cas9 KOプラスミド (h) | sc-401766 | h | Gene Knockout | GFP | 0 | ||
ANG I HDRプラスミド (h2) | sc-401766-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
ANG I Double Nickaseプラスミド (h) | sc-401766-NIC | h | Gene Knockout | Puromycin | 0 | ||
ANG I Double Nickaseプラスミド (h2) | sc-401766-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ANG I CRISPR/Cas9 KOプラスミド (m) | sc-419104 | m | Gene Knockout | GFP | 0 | ||
ANG I HDRプラスミド (m) | sc-419104-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ANG I Double Nickaseプラスミド (m) | sc-419104-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANG I Double Nickaseプラスミド (m2) | sc-419104-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ANG III CRISPR/Cas9 KOプラスミド (m) | sc-419105 | m | Gene Knockout | GFP | 0 | ||
ANG III Double Nickaseプラスミド (m) | sc-419105-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANG III Double Nickaseプラスミド (m2) | sc-419105-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ANG IV CRISPR/Cas9 KOプラスミド (m) | sc-432340 | m | Gene Knockout | GFP | 0 | ||
ANG IV HDRプラスミド (m) | sc-432340-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ANG IV Double Nickaseプラスミド (m) | sc-432340-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANG IV Double Nickaseプラスミド (m2) | sc-432340-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ANG VI CRISPR/Cas9 KOプラスミド (m) | sc-437010 | m | Gene Knockout | GFP | 0 | ||
ANG VI HDRプラスミド (m) | sc-437010-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ANG VI Double Nickaseプラスミド (m) | sc-437010-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANG VI Double Nickaseプラスミド (m2) | sc-437010-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ANGRP CRISPR/Cas9 KOプラスミド (m) | sc-419106 | m | Gene Knockout | GFP | 0 | ||
ANGRP HDRプラスミド (m) | sc-419106-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ANGRP Double Nickaseプラスミド (m) | sc-419106-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANGRP Double Nickaseプラスミド (m2) | sc-419106-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Angiogenin CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ANG I CRISPR Activationプラスミド (h) | sc-401766-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I CRISPR Activationプラスミド (h2) | sc-401766-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I Lentiviral Activation Particles (h) | sc-401766-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I Lentiviral Activation Particles (h2) | sc-401766-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I CRISPR Activationプラスミド (m) | sc-419104-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I CRISPR Activationプラスミド (m2) | sc-419104-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I Lentiviral Activation Particles (m) | sc-419104-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG I Lentiviral Activation Particles (m2) | sc-419104-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG III CRISPR Activationプラスミド (m) | sc-419105-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG III CRISPR Activationプラスミド (m2) | sc-419105-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG III Lentiviral Activation Particles (m) | sc-419105-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG III Lentiviral Activation Particles (m2) | sc-419105-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG IV CRISPR Activationプラスミド (m) | sc-432340-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG IV CRISPR Activationプラスミド (m2) | sc-432340-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG IV Lentiviral Activation Particles (m) | sc-432340-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG IV Lentiviral Activation Particles (m2) | sc-432340-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG VI CRISPR Activationプラスミド (m) | sc-437010-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG VI CRISPR Activationプラスミド (m2) | sc-437010-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG VI Lentiviral Activation Particles (m) | sc-437010-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANG VI Lentiviral Activation Particles (m2) | sc-437010-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANGRP CRISPR Activationプラスミド (m) | sc-419106-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANGRP CRISPR Activationプラスミド (m2) | sc-419106-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANGRP Lentiviral Activation Particles (m) | sc-419106-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANGRP Lentiviral Activation Particles (m2) | sc-419106-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Angiogenin siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ANG I siRNA (h) | sc-39291 | h | Gene Silencing | N/A | 3 | ||
ANG I shRNA プラスミド (h) | sc-39291-SH | h | Gene Silencing | Puromycin | 3 | ||
ANG I shRNA (h) レンチウイルス粒子 | sc-39291-V | h | Gene Silencing | Puromycin | 3 | ||
ANG I siRNA (m) | sc-39292 | m | Gene Silencing | N/A | 0 | ||
ANG I shRNA プラスミド (m) | sc-39292-SH | m | Gene Silencing | Puromycin | 0 | ||
ANG I shRNA (m) レンチウイルス粒子 | sc-39292-V | m | Gene Silencing | Puromycin | 0 | ||
ANG III/V siRNA (m) | sc-39296 | m | Gene Silencing | N/A | 0 | ||
ANG III/V shRNA プラスミド (m) | sc-39296-SH | m | Gene Silencing | Puromycin | 0 | ||
ANG III/V shRNA (m) レンチウイルス粒子 | sc-39296-V | m | Gene Silencing | Puromycin | 0 | ||
ANG IV siRNA (m) | sc-39298 | m | Gene Silencing | N/A | 0 | ||
ANG IV shRNA プラスミド (m) | sc-39298-SH | m | Gene Silencing | Puromycin | 0 | ||
ANG IV shRNA (m) レンチウイルス粒子 | sc-39298-V | m | Gene Silencing | Puromycin | 0 | ||
ANG VI siRNA (m) | sc-141058 | m | Gene Silencing | N/A | 0 | ||
ANG VI shRNA プラスミド (m) | sc-141058-SH | m | Gene Silencing | Puromycin | 0 | ||
ANG VI shRNA (m) レンチウイルス粒子 | sc-141058-V | m | Gene Silencing | Puromycin | 0 | ||
ANGRP siRNA (m) | sc-39294 | m | Gene Silencing | N/A | 0 | ||
ANGRP shRNA プラスミド (m) | sc-39294-SH | m | Gene Silencing | Puromycin | 0 | ||
ANGRP shRNA (m) レンチウイルス粒子 | sc-39294-V | m | Gene Silencing | Puromycin | 0 |